scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1033287285 |
P356 | DOI | 10.1186/S12967-016-0908-7 |
P932 | PMC publication ID | 4897890 |
P698 | PubMed publication ID | 27268027 |
P50 | author | Piercarlo Sarzi-Puttini | Q30002194 |
Maria Rita Gismondo | Q40791898 | ||
P2093 | author name string | Alessandra Lombardi | |
Enzo Massimo Caruso | |||
Salvatore Santandrea | |||
Franco Montrone | |||
Innocenzo Caruso | |||
P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
Putting a face to MHC restriction | Q28299372 | ||
The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis | Q68109843 | ||
Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong | Q68489082 | ||
[Rheumatoid synovitis of the knee, treated successfully with intra-articular rifamycin SV] | Q70316830 | ||
Rifamycin SV administered by intra-articular infiltrations shows disease modifying activity in patients with pauci- or polyarticular juvenile rheumatoid arthritis | Q72252839 | ||
Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis | Q72891612 | ||
Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent | Q78025335 | ||
Depressed proliferative responses by peripheral blood mononuclear cells from early arthritis patients to mycobacterial heat shock protein 60 | Q78169200 | ||
Do all drugs and treatments for rheumatoid arthritis have the same efficacy? | Q81138145 | ||
Towards a network theory of the immune system. | Q34202813 | ||
Role for innate immunity in rheumatoid arthritis | Q36024454 | ||
The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal | Q36079214 | ||
B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? | Q36106119 | ||
T cell epitope-specific immune therapy for rheumatic diseases | Q36356746 | ||
A circulating reservoir of pathogenic-like CD4+ T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment | Q36577387 | ||
The role of B cells in animal models of rheumatoid arthritis | Q36664672 | ||
Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis | Q37356882 | ||
Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans | Q37525926 | ||
Innate immunity and rheumatoid arthritis | Q37761419 | ||
B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives | Q37903458 | ||
The ins and outs of MHC class II-mediated antigen processing and presentation | Q38365560 | ||
Injection of the rheumatoid knee: does intra-articular methotrexate or rifampicin add to the benefits of triamcinolone hexacetonide? | Q39445380 | ||
Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. | Q41129052 | ||
Twenty years of experience with intra-articular rifamycin for chronic arthritides | Q41680058 | ||
Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients | Q41822323 | ||
Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase I | Q41937377 | ||
The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. | Q43872556 | ||
TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis | Q44663546 | ||
Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis | Q45304911 | ||
Pan-DR-binding Hsp60 self epitopes induce an interleukin-10-mediated immune response in rheumatoid arthritis. | Q46020051 | ||
Rifamycin SV in the Treatment of Knee Synovitis | Q46789755 | ||
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis | Q47643186 | ||
In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. | Q50193209 | ||
A theory of regulation and self-nonself discrimination in an immune network. | Q52244772 | ||
Clinical improvement in ankylosing spondylitis with rifamycin SV infiltrations of peripheral joints. | Q54065722 | ||
Rifamycin SV in local treatment of synovitis--a clinical, arthroscopic and pharmacologic evaluation. | Q54253660 | ||
Treatment of adjuvant arthritis in rats: Vaccination potential of a synthetic nonapeptide from the 65 kDa heat shock protein of mycobacteria | Q67657519 | ||
Prevention of appearance of radiological lesions in early rheumatoid arthritis: a randomized, single-blind study comparing intra-articular rifamycin with auranofin | Q68100655 | ||
P433 | issue | 1 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 162 | |
P577 | publication date | 2016-06-07 | |
P1433 | published in | Journal of Translational Medicine | Q15716664 |
P1476 | title | Vaccination with endosomal unknown epitopes produces therapeutic response in rheumatoid arthritis patients and modulates adjuvant arthritis of rats | |
P478 | volume | 14 |